ACM
IOVA icon

Armbruster Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Armbruster Capital Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,200
Closed -$16K – 267
2017
Q2 		$16K Hold
2,200
– – 0.01% 187
2017
Q1 		$16K Hold
2,200
– – 0.01% 189
2016
Q4 		$15K Hold
2,200
– – 0.01% 193
2016
Q3 		$18K Buy
+2,200
New +$18.6K 0.01% 183

Other funds holding IOVA

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $141M AUM 783.79% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return